Technology: Cell_Therapies
Industry: AI, Early Drug Development
Headquarters: Shanghai, Shanghai, China
Founded Date: 2008-01-01
Employees Number: 101-250
Funding Status: IPO
Number Of Exits: 1
Acquisitions Number: 1
Investors Number: 6
Total Funding: 37464000
Estimated Revenue: $10M to $50M
Last Funding Date: 2018-07-13
Last Funding Type: Series B

Visit Website
Register and Claim Ownership